Brazil is so far free from Candida auris. Are we missing something?

Pasqualotto, Alessandro C; Sukiennik, Teresa C T; Meis, Jacques F.
Braz. j. infect. dis ; 23(3): 149-150, May-June 2019.
Artículo en Inglés | LILACS | ID: biblio-1019552

Documentos relacionados

  1. Insights into the Unique Nature of the East Asian Clade of the Emerging Pathogenic Yeast Candida auris.
  2. Thinking beyond the Common Candida Species: Need for Species-Level Identification of Candida Due to the Emergence of Multidrug-Resistant Candida auris.
  3. Emerging Multidrug-Resistant Candida duobushaemulonii Infections in Panama Hospitals: Importance of Laboratory Surveillance and Accurate Identification.
  4. Candida auris Clinical Isolates from South Korea: Identification, Antifungal Susceptibility, and Genotyping.
  5. Chymotrypsin- and trypsin-like activities secreted by the multidrug-resistant yeasts forming the Candida haemulonii complex.
  6. Multidrug transporters of Candida species in clinical azole resistance.
  7. Molecular identification of Candida auris by PCR amplification of species-specific GPI protein-encoding genes.
  8. Is the superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris.
  9. Can Multidrug-Resistant Candida auris Be Reliably Identified in Clinical Microbiology Laboratories?
  10. Different classes of hydrolytic enzymes produced by multidrug-resistant yeasts comprising the Candida haemulonii complex.